|
|
Other links at Articles > Business of Medicine |
| 4. |
Heart-Imaging Agent Gets FDA Approval
|
|
|
Drug makers CV Therapeutics and Astellas Pharma Inc said on Friday the U.S. Food and Drug Administration (FDA) had approved their heart-imaging agent regadenoson, also called Lexiscan. Reuters Health Information
|
|
|